g10 fx
Citi raises AstraZeneca target to £186 as tozorakimab prospects improve - Yahoo Finance UK
Citi
From the original
Citi raises AstraZeneca target to £186 as tozorakimab prospects improve Yahoo Finance UK
Related speeches
4 itemsCiti raises target for AstraZeneca stock to GBp 18,600 - AD HOC NEWS
Deutsche Bank upgrades AstraZeneca stock rating to hold on trial results - Investing.com Nigeria
Goldman Sachs raises target for Novartis stock to CHF 113.00 - AD HOC NEWS
Citi keeps Antofagasta at £44 target despite lower 2026 copper forecast - Yahoo Finance UK
More like this
5 itemsUBS downgrades Pearson as share gains leave limited room for upside - Yahoo Finance UK
GBP/USD Consolidates as Outlook Remains Mixed - Investing.com
UBS downgrades Pearson stock rating to neutral on valuation - Investing.com
Novo Nordisk stock target cut at Citi on lack of margin growth - Yahoo Finance UK